send mail to firstname.lastname@example.org mentioning your email id and mobileno registered with us! if details not recieved
Resend Opt after 60 Sec.
Please verify your mobile number
Please update your name
Subscribe to Notifications
Stay updated with the latest Current affairs and other important updates regarding video Lectures, Test Schedules, live sessions etc..
Refer & Earn
My Abhipedia Earning
Kindly Login to view your earning
Vice President of India, M. Venkaiah Naidu, launched “Vaccinate India Programme” on August 24, 2021. On the occasion, he appealed to the people to strictly follow COVID-19 norms.
India started its COVID-19 vaccines programme on January 16, 2021. As of August 23, more than 588 doses have been administered including first and second doses of recently approved vaccines. India firstly approved the Oxford–AstraZeneca vaccine that was manufactured under license by Serum Institute of India & named as Covishield as well as Covaxin that was developed locally by Bharat Biotech. These vaccines have now been joined by Sputnik V, Moderna vaccines, ZyCoV-D and Johnson & Johnson. India crossed the milestone of 500 million doses on August 6, 2021 within 6 months of onset of the vaccination program.
DGCI approved emergency use of Johnson and Johnson single-dose vaccine on August 7, 2021.
Sputnik V is being manufactured under license by Dr. Reddy’s Laboratories, with additional production from Serum Institute of India to be started from September 2021.
India granted the emergency use approval for world’s first DNA based COVID-19 vaccine called ZyCoV-D on August 20, 2021. It has been manufactured by Zydus Cadila for adults and children aged 12 years and more. This vaccine is administered through a needle-free applicator.
By: Brijesh Kumar ProfileResourcesReport error
Access to prime resources